Beacon Prescriptions (DCA Inc.), Southington, CT
Is Beacon Prescriptions (DCA Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Beacon Prescriptions (DCA Inc.) hold a Connecticut pharmacy license?
The Connecticut Department of Consumer Protection lists license PCY.0001334 for BEACON PRESCRIPTIONS, SOUTHINGTON, status ACTIVE (CURRENT), as of Nov 15, 2026.
Has Beacon Prescriptions (DCA Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Sep 22, 2021), 1 state referral letter (Sep 22, 2021) and 1 FMD-145 letter (Sep 22, 2021) for Beacon Prescriptions (DCA Inc.). Connecticut board disciplinary actions: not checked, because the Connecticut Department of Consumer Protection data this index reads gives license status only and does not include disciplinary actions. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- DCA Inc.; Beacon Prescriptions
- Location
- Southington, CT
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Sep 22, 2021
- FDA Data Dashboard inspections
- 1 inspection: 1 NAI; 1 published Form 483
- State board records
- License found: PCY.0001334, ACTIVE (CURRENT)
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as DCA Inc. (dba Beacon Prescriptions), a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Sep 22, 2021 | State referral letter | State Referral Letter 09/22/2021 | Not linked by FDA |
| Sep 22, 2021 | FMD-145 letter | FMD-145 Letter 09/22/2021 | Not linked by FDA |
| Sep 22, 2021 | Warning letter close-out | Warning Letter Closeout 09/22/2021 | Not linked by FDA |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists DCA, Inc., Southington, CT (FEI number 3005823862), matched to this page by exact name, city and state. It lists 1 inspection: 1 NAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jun 21, 2018 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs) | 3005823862 | 1059992 |
Form 483s FDA has published for this site
- Dec 23, 2016: Form 483 to DCA, Inc., published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Beacon Prescriptions (DCA Inc.), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Dec 23, 2016: FDA document 101661: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
The Connecticut Department of Consumer Protection file dated Nov 15, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| PCY.0001334 | PHARMACY | BEACON PRESCRIPTIONS | SOUTHINGTON | ACTIVE (CURRENT) |
What this covers: The dataset gives each license’s status and status reason in the department’s words but lists no disciplinary actions, so Connecticut board actions are not checked.
Close but not exact board records
These board records share a name with this pharmacy but did not meet this index’s matching rule (same name, same city, same state), so they are not treated as its license. They may belong to a separate business.
- License PCY.0000010, BEACON PRESCRIPTIONS, EAST HAVEN, status ACTIVE (CURRENT): same name and state, different city.
- License PCY.0000332, BEACON PRESCRIPTIONS, NEW BRITAIN, status ACTIVE (CURRENT): same name and state, different city.
- License PCY.0001086, BEACON PRESCRIPTIONS, BRISTOL, status ACTIVE (CURRENT): same name and state, different city.
- License PCY.0001719, BEACON PRESCRIPTIONS, WINSTED, status INACTIVE: same name and state, different city.
- License PCY.0002243, BEACON PRESCRIPTIONS, VERNON ROCKVILLE, status INACTIVE (WITHDRAWN): same name and state, different city.
- License PCY.0002391, BEACON PRESCRIPTIONS, NEW BRITAIN, status ACTIVE (CURRENT): same name and state, different city.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- Connecticut Department of Consumer Protection license file
Records last pulled Nov 15, 2026. Every entry links to the original public record.